Pharmaceuticals

Drug Development Drug Pricing Drug Safety Drug Approval Weight Loss Drugs Prescription Drugs Clinical Trials Drug Manufacturing Drug Regulation Prescription Medications

Meridian’s Q3 Letter Highlights FIGR’s Marketplace Scale and J&J’s Pipeline Progress

The fund stresses stock-specific catalysts as its hedged approach lagged a policy-driven rally.

Sanofi to Acquire Dynavax for $2.2 Billion in Cash Tender Offer

Stories older than 24h

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

BioMarin to Acquire Amicus for $4.8 Billion in Cash

Trump Adds Nine Pharma Giants to Drug Pricing Deals, Reaching 14 Signatories as TrumpRx Nears Launch

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

JPMorgan Upgrades Recursion, Raises Target to $11 as Shares Surge on AI Drug Signals

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

FDA Grants Fast Track to Palvella’s QTORIN Rapamycin for Angiokeratomas

SK Capital Affiliate to Invest in Swixx BioPharma at Valuation Above €1.5 Billion

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Novo Nordisk Presses India Expansion and Higher-Dose Push as Analyst Views Diverge

Ontario ADHD Stimulant Prescriptions Jump 157% Since 2015, With Fastest Growth in Adult Women

FDA Panel Urges Looser Testosterone Rules, Including Descheduling and Broader Use

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs

Formycon, Zydus Seal Exclusive Deal for Keytruda Biosimilar in U.S. and Canada